Hanmi to market bone transplant materials

Published: 2009-12-24 06:56:00

Updated: 2009-12-24 06:56:00

Hami Pharm said on December 21 that it has marketed SureFuse and ExFuse, bone transplant products developed by Hans Biomed, a local medical provider.

SureFuse and ExFuse are the mixtures of DBM (Demineralized Bone Matrix) and help to form normal healthy bone by stimulation of mesenchymal cell ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK